Omkar Pharmachem Complete Financial Statements
In FYNone, Omkar Pharmachem (OMKARPH) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.20. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see OMKARPH company profile.
11 Years of Data
2025 - 2015
Complete Financial Data Export
Profitability Ratios
Operating Margin
54.00%
2025 data
Balance Sheet Ratios
Debt to Equity
1.11
2025 data
Equity Ratio
90.00%
2025 data
Asset Turnover
0.10
2025 data
OMKARPH Revenue, Net Profit & EBITDA — Year-on-Year Growth
OMKARPH YoY (March 2025 vs Period) — revenue -100.0%.
Revenue Growth
-100.0%
Year-over-Year
OMKARPH Income Statement — Revenue, EBITDA & Net Profit
Omkar Pharmachem revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.20 (None). Explore OMKARPH Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 54.00% | 52.00% | 58.00% | 50.00% | 8.00% | -454.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.20 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 | -0.26 | -0.42 | -0.25 | 0.22 | -0.12 | -0.06 |
OMKARPH Balance Sheet — Assets, Liabilities & Shareholders' Equity
OMKARPH total assets ₹10 Cr, total equity ₹9 Cr, total liabilities ₹10 Cr (2025).
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 10 | 9 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 9 |
| LIABILITIES | |||||||||||
| Total Liabilities | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 10 | 9 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 | -1 |
OMKARPH Cash Flow Statement — Operating, Investing & Financing
Omkar Pharmachem operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |